301 related articles for article (PubMed ID: 20473892)
41. Proliferative and metastatic roles for Phospholipase D in mouse models of cancer.
Roth E; Frohman MA
Adv Biol Regul; 2018 Jan; 67():134-140. PubMed ID: 29154090
[TBL] [Abstract][Full Text] [Related]
42. ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K/Akt/NF-κB signaling pathway.
Ren D; Jia L; Li Y; Gong Y; Liu C; Zhang X; Wang N; Zhao Y
IUBMB Life; 2014 Apr; 66(4):300-8. PubMed ID: 24756995
[TBL] [Abstract][Full Text] [Related]
43. Ral isoforms are implicated in Fc gamma R-mediated phagocytosis: activation of phospholipase D by RalA.
Corrotte M; Nyguyen AP; Harlay ML; Vitale N; Bader MF; Grant NJ
J Immunol; 2010 Sep; 185(5):2942-50. PubMed ID: 20679536
[TBL] [Abstract][Full Text] [Related]
44. Up-regulation of cyclooxygenase-2 by cobalt chloride-induced hypoxia is mediated by phospholipase D isozymes in human astroglioma cells.
Ahn BH; Park MH; Lee YH; Kwon TK; Min do S
Biochim Biophys Acta; 2007 Dec; 1773(12):1721-31. PubMed ID: 17640750
[TBL] [Abstract][Full Text] [Related]
45. Phospholipase D is a target for inhibition of astroglial proliferation by ethanol.
Burkhardt U; Wojcik B; Zimmermann M; Klein J
Neuropharmacology; 2014 Apr; 79():1-9. PubMed ID: 24262632
[TBL] [Abstract][Full Text] [Related]
46. Phosphatidic Acid Increases Epidermal Growth Factor Receptor Expression by Stabilizing mRNA Decay and by Inhibiting Lysosomal and Proteasomal Degradation of the Internalized Receptor.
Hatton N; Lintz E; Mahankali M; Henkels KM; Gomez-Cambronero J
Mol Cell Biol; 2015 Sep; 35(18):3131-44. PubMed ID: 26124282
[TBL] [Abstract][Full Text] [Related]
47. α1 -Adrenergic receptor-induced cytoskeletal organization and cell motility in CCL39 fibroblasts requires phospholipase D1.
Wallert M; McCoy A; Voog J; Rastedt D; Taves-Patterson J; Korpi-Steiner N; Canine J; Ngyuen T; Nguyen C; Provost J
J Cell Biochem; 2011 Oct; 112(10):3025-34. PubMed ID: 21678474
[TBL] [Abstract][Full Text] [Related]
48. PLD1 regulates adipogenic differentiation through mTOR - IRS-1 phosphorylation at serine 636/639.
Song HI; Yoon MS
Sci Rep; 2016 Nov; 6():36968. PubMed ID: 27872488
[TBL] [Abstract][Full Text] [Related]
49. Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2.
Joseph T; Wooden R; Bryant A; Zhong M; Lu Z; Foster DA
Biochem Biophys Res Commun; 2001 Dec; 289(5):1019-24. PubMed ID: 11741292
[TBL] [Abstract][Full Text] [Related]
50. Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras.
Shi M; Zheng Y; Garcia A; Xu L; Foster DA
Cancer Lett; 2007 Dec; 258(2):268-75. PubMed ID: 17949898
[TBL] [Abstract][Full Text] [Related]
51. Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them.
Zhang Y; Redina O; Altshuller YM; Yamazaki M; Ramos J; Chneiweiss H; Kanaho Y; Frohman MA
J Biol Chem; 2000 Nov; 275(45):35224-32. PubMed ID: 10926929
[TBL] [Abstract][Full Text] [Related]
52. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Kim SO; Kim MR
Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
[TBL] [Abstract][Full Text] [Related]
53. The phospholipase D pathway mediates the inflammatory response of the retinal pigment epithelium.
Mateos MV; Kamerbeek CB; Giusto NM; Salvador GA
Int J Biochem Cell Biol; 2014 Oct; 55():119-28. PubMed ID: 25172550
[TBL] [Abstract][Full Text] [Related]
54. Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells.
Eisen SF; Brown HA
Mol Pharmacol; 2002 Oct; 62(4):911-20. PubMed ID: 12237338
[TBL] [Abstract][Full Text] [Related]
55. Selective activation of nuclear phospholipase D-1 by g protein-coupled receptor agonists in vascular smooth muscle cells.
Gayral S; Déléris P; Laulagnier K; Laffargue M; Salles JP; Perret B; Record M; Breton-Douillon M
Circ Res; 2006 Jul; 99(2):132-9. PubMed ID: 16778131
[TBL] [Abstract][Full Text] [Related]
56. Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models.
Borel M; Cuvillier O; Magne D; Mebarek S; Brizuela L
Mol Cell Biochem; 2020 Oct; 473(1-2):263-279. PubMed ID: 32661773
[TBL] [Abstract][Full Text] [Related]
57. PLD regulates myoblast differentiation through the mTOR-IGF2 pathway.
Yoon MS; Chen J
J Cell Sci; 2008 Feb; 121(Pt 3):282-9. PubMed ID: 18198186
[TBL] [Abstract][Full Text] [Related]
58. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of phospholipase D2 induces autophagy in colorectal cancer cells.
Hwang WC; Kim MK; Song JH; Choi KY; Min do S
Exp Mol Med; 2014 Dec; 46(12):e124. PubMed ID: 25475140
[TBL] [Abstract][Full Text] [Related]
60. Phospholipase D1, but not D2, regulates protein secretion via Rho/ROCK in a Ras/Raf-independent, MEK-dependent manner in rat lacrimal gland.
Hodges RR; Guilbert E; Shatos MA; Natarajan V; Dartt DA
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2199-210. PubMed ID: 21212180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
